Discovery of aggressive cancer cell types by Vanderbilt researchers made possible with machine learning techniques
Jun. 24, 2020—Rebecca Ihrie and Jonathan Irish are leading the development of machine learning applications for brain cancer research.
Jun. 11, 2020—The VICC SPORE in Breast Cancer announces a Career Enhancement Program funding opportunity that aims to attract, develop and mentor promising basic, translational and population-based research scientists, including physician scientists, into breast cancer research.
Jun. 11, 2020—The VICC SPORE in Breast Cancer announces a Developmental Research Program pilot funding opportunity focused on catalyzing innovative and transformative breast cancer-related projects that promote discoveries in basic and translational research focused on metastatic disease.
Sep. 25, 2019—An engineering professor has received financial support from Susan G. Komen for breast cancer research. His project is among 60 grants totaling $26 million awarded to researchers nationwide. Those initiatives are focused on improving outcomes for metastatic breast cancer, reducing disparities in survivorship and developing new, more effective treatments. John T. Wilson, assistant professor of...
Feb. 28, 2019—A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.
Feb. 21, 2019—An international team involving Vanderbilt researchers has discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer.
Jan. 17, 2019—Brian Engelhardt is studying why as many as 50 percent of stem cell transplant recipients develop diabetes.
May. 26, 2017—Vanderbilt-Ingram Cancer Center (VICC), in collaboration with the Hereditary Cancer Program and the Vanderbilt Breast Center, is hosting a free seminar, “Are You at High Risk for Breast Cancer?”
Apr. 20, 2017—Leading cancer investigators from several prominent universities and laboratories will headline the 2017 Vanderbilt-Ingram Cancer Center (VICC) Annual Scientific Retreat May 4.
Mar. 23, 2017—The Meharry Medical College, Vanderbilt-Ingram Cancer Center (VICC) and Tennessee State University (TSU) Cancer Partnership will host its 16th Annual Cancer Retreat on April 8.
Sep. 16, 2016—Listening to the body and being aware of individual risks are especially important when it comes to ovarian cancer. Vanderbilt–Ingram Cancer Center provides the facts.
Feb. 4, 2016—In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer.